SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is surging amid news of a $5B financing deal, unlocking significant capital for AI data centers and eliminating shareholder dilution concerns, which has sparked a short squeeze frenzy. The community is buzzing about potential hyperscaler partnerships and upgraded price targets, fueling speculation of a continued rally. With high short interest and positive catalysts, APLD is gaining attention as a key player in the AI infrastructure buildout.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ ($LAES) is surging due to a strategic partnership focused on developing quantum-resistant chips for U.S. defense applications, fueling speculation about lucrative government contracts. The community is buzzing about the company's growth potential and comparing it to other players in the quantum computing space, with some investors believing LAES is undervalued and predicting a significant climb.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is gaining traction as community members express excitement, referencing an imminent listing on Moonshot and calling for others to "RAGE" harder. Fueling the hype, some are alluding to potential breakouts and increased liquidity, while others point to the project's roots in OG internet meme culture. The community's focus remains on strong community building and promoting the idea of everyone making it.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as chatter increases around a potential short squeeze, with the community noting high short interest and open call option volume. Recent developments, including a major financial endorsement and increased stake from Alphabet Inc., have boosted optimism. Discussions also involve TeraWulf's shift towards AI and high-performance computing, similar to peers in the sector.

GSR III Acquisition Corp engages in the merger, share exchange, asset acquisition, share purchase or reorganization with one or more businesses. The company was founded on May 10, 2023 and is headquartered in Austin, Texas.

GSR III Acquisition Corp. - Ordinary Shares- Class A

GSR III Acquisition Corp. Ordinary Shares

GSRT is trending due to the imminent ticker change to NKLR following its merger with Terra Innovatum, a micro-modular nuclear reactor developer; the change is expected to occur soon. Community members are excited about the potential, drawing comparisons to OKLO and highlighting the growing demand for nuclear energy. Discussions also include the stock's valuation relative to its peers and expectations for increased volume and volatility post-ticker change.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is trending as silver prices approach multi-decade highs, sparking discussions about a potential breakout. Community members are actively discussing the possibility of a short squeeze and the impact of supply deficits on prices. Some analysts point to a long-term cup and handle formation, suggesting a bullish outlook, while others debate potential pullbacks and profit-taking opportunities.

One and one Green Technologies. Inc - Ordinary Shares - Class A

YDDL is trending due to its recent IPO and subsequent volatile price action, with the stock experiencing significant gains and drops. The community is actively discussing its low float, high insider ownership, and potential for both further gains and significant losses, with some expressing concerns about it being a pump and dump. Some traders are also looking at other AI and Green Tech names like $APLD and $HIVE.

Zoracles

Zoracles (ZORA) is trending following its recent listing on Robinhood, leading to increased exposure and new investors. The community is actively discussing its potential within the BASE ecosystem and drawing comparisons to other social media platforms.  Many are anticipating further gains and upward momentum, while some caution against potential pullbacks.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as community members discuss its potential breakout and growing institutional attention. Some see it as the next Palantir, fueled by the AI infrastructure wave, while others point to strong call volume and potential short squeeze dynamics. Discussions also highlight UiPath's strategic shift towards agentic AI and partnerships with major tech players.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as traders debate market manipulation and the impact of potential tariffs, with some expressing concerns over valuations and debt sustainability. Community discussions revolve around government shutdowns, peace deals, and their seemingly counterintuitive effects on market behavior, questioning the influence of market makers and options cycles. Despite a slight dip, many anticipate a continued rally, while others foresee a significant correction, driven by overbought conditions and various economic uncertainties.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates

Intellia Therapeutics (NTLA) delivered earnings and revenue surprises of +3.88% and +9.43%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Brokerages Set ProQR Therapeutics (NASDAQ:PRQR) Target Price at $3.80

ProQR Therapeutics (NASDAQ:PRQR - Get Free Report) has been given a consensus rating of "Buy" by the four research firms that are covering the company, MarketBeat Ratings reports. Four investment...

Chardan Capital Boosts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $2.50

ProQR Therapeutics (NASDAQ:PRQR  Get Free Report) had its target price lifted by Chardan Capital from $2.00 to $2.50 in a note issued to investors on Thursday, Benzinga reports. The brokerage...

ProQR Therapeutics sees cash runway into mid-2026

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

ProQR Therapeutics reports 2023 EPS (EUR 0.35) vs. (EUR 0.90) last year

ProQR Announces Year End 2023 Operating and Financial Results

Preclinical and translational pipeline program data for AX-0810 for Cholestatic Diseases targeting NTCP and AX-1412 for Cardiovascular Disease targeting B4GALT1 anticipated in 2024, building further...

ProQR Therapeutics (NASDAQ:PRQR) Given Average Rating of "Buy" by Analysts

ProQR Therapeutics (NASDAQ:PRQR  Get Free Report) has been assigned a consensus rating of Buy from the five research firms that are covering the company, Marketbeat Ratings...

ProQR Announces Japanese Axiomer  Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing

LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies...

ProQR Therapeutics (NASDAQ:PRQR) Rating Increased to Buy at StockNews.com

ProQR Therapeutics (NASDAQ:PRQR  Get Free Report) was upgraded by equities research analysts at StockNews.com from a hold rating to a buy rating in a report...

Shares of ProQR Therapeutics (NASDAQ:PRQR  Get Free Report) have received a consensus recommendation of Buy from the five ratings firms that are covering the firm, Marketbeat...

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Platenburg, Henri A. Termeer, and Domenico Valerio on February 21, 2012, and is headquartered in Leiden, the Netherlands.

ProQR Therapeutics N.V

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$2.50
Prev Close	$2.36
Open	$2.37
Dividend Yield	0.00%
50-Day Moving Average	$2.17
Beta	0.77
Avg. Volume	390,627.52
PE Ratio	-5.32

52-Week High	$4.62
52-Week Low	$1.07
Market Capitalization	$248.3M
EPS (Annual)	-$0.3488
Price to Book	3.16
Revenue Per Employee	$123,114.77
Enterprise Value/EBITDA	N/A

PRQR
ProQR Therapeutics N.V

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PRQR News

PRQRProQR Therapeutics N.V